Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Apply
GV20-0251, Pembrolizumab
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step